Diploma (LON:DPLM – Get Free Report)‘s stock had its “outperform” rating reiterated by Royal Bank Of Canada in a research note issued on Tuesday, Digital Look reports. They currently have a GBX 7,400 price target on the stock. Royal Bank Of Canada’s target price would indicate a potential upside of 4.08% from the stock’s previous close.
Other equities analysts have also recently issued research reports about the company. Jefferies Financial Group restated a “hold” rating and set a GBX 7,000 price objective on shares of Diploma in a report on Friday, May 29th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the company a “buy” rating in a research note on Wednesday, May 20th. JPMorgan Chase & Co. upped their price target on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a report on Monday, August 24th. Finally, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 9,000 price target on shares of Diploma in a research note on Monday, July 20th. Six research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of GBX 7,400.
Check Out Our Latest Analysis on Diploma
Diploma Stock Down 0.8%
Insiders Place Their Bets
In related news, insider Wilson Ng bought 424 shares of the company’s stock in a transaction on Thursday, July 16th. The shares were acquired at an average price of GBX 7,066 per share, with a total value of £29,959.84. Also, insider Katie Bickerstaffe purchased 47 shares of the business’s stock in a transaction dated Thursday, July 16th. The stock was bought at an average price of GBX 7,050 per share, for a total transaction of £3,313.50. Insiders purchased a total of 1,604 shares of company stock worth $11,447,718 over the last 90 days. Company insiders own 1.14% of the company’s stock.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
- Five stocks we like better than Diploma
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
